14 Feb The Sativex Scandal Deepens. Corruption And Dishonesty At The Home Office
Whose Pockets Are Being Filled By The British Government’s Corrupt Cannabis Policy?
The mists of deception and the stench of corruption are swirling around the Home Office and GW Pharmaceuticals.
Yesterday’s ‘advice’ from the Advisory Council on the Misuse of Drugs on Sativex finally reveals the council to be the propaganda tool of the government.
However many times you may have given Marsham Street the benefit of the doubt, now is the time to face facts. Since the disgraceful sacking of Professor Nutt, the ACMD has deteriorated into a sham, a rubber stamping exercise for the Home Office and the racist, cruel and failed ‘war on drugs’. It is a subversion of the Misuse of Drugs Act 1971 (MoDA), the statute that brought it into existence.
Those involved in it are as guilty of ‘misconduct in public office’ as any bent cop selling information to Fleet Street. Worse than that, they are engaged in deliberately causing harm to sick and disabled people in order to secure and promote GW Pharma’s unlawful monopoly on medicinal cannabis.
Sativex is an whole plant extract of cannabis which contains all the compounds present in the plants from which it is made. Indeed, according to Dr Geoffrey Guy, chairman of GW Pharma “It has 420 molecules, whereas every other drug has just one.”
There is only one scientifically accurate way to describe Sativex. It is cannabis. That is the only honest definition which can properly be used to define Sativex in the Misuse of Drugs Regulations 2001.
However, this is the definition that the ACMD has recommended to the Home Office:
“A liquid formulation-
(a) containing a botanical extract of Cannabis –
(i) with a concentration of not more than 30 milligrammes of cannabidiol per millilitre, and not more than 30 milligrammes of delta-9-tetrahydrocannabinol per millilitre,
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3
(b) which is dispensed through a metered dose pump as a mucosal mouth spray and
which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency (MHRA)”
Every other drug is defined in the regulations by a single word. No other drug specifies its method of delivery. No other drug is defined by its MHRA approval.
And the “metered dose pump as a mucosal mouth spray” is patented by GW Pharma so its monopoly of medicinal cannabis, already unlawful under competition law and produced under an unlawful licence, is to be enshrined in UK statute. Where else does a privately owned enterprise enjoy such a monopoly and such statutory protection?
The schedules in the Misuse of Drugs Regulations 2001 can be seen here. There are some definitions that extend beyond a single word but only when they seek to define whole groups or type of drug. This dishonest contrivance about Sativex is transparent. It is a deception designed to avoid and subvert the will of parliament expressed in the MoDA.
Cannabis is a safe, very effective medicine for a wide range of conditions which can be treated by modulating the body’s endocannabinoid system. It can be produced very quickly, cheaply and easily and ingested in ways that do not involve smoking – although for some people smoking will be best. The evidence is conclusive that not only does neat cannabis not cause cancer or COPD but it actually protects the lungs and other major organs including the brain. It may even reverse dementia.
Sativex is a good, effective product but priced at a ridiculous , exploitative level and produced and regulated under a corrupt system. Most people can gain more safe, genuine therapeutic benefit from natural herbal cannabis which, with modest skill, they can grow for themselves. Alternatively, they could buy it from a licensed outlet under a properly regulated system which would far better protect children than the present criminal market.